These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14199708)

  • 1. EXPERIENCE WITH STREPTOKINASE AS A THROMBOLYTIC AGENT.
    WINCKELMANN G; HIEMEYER V
    Scand J Clin Lab Invest; 1964; 16():SUPPL 79:7-14. PubMed ID: 14199708
    [No Abstract]   [Full Text] [Related]  

  • 2. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS.
    LEWIS JH; SHIRAKAWA M
    Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
    HELLE I; AAS K; GODAL HC
    Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607
    [No Abstract]   [Full Text] [Related]  

  • 4. FIBRINOLYTIC THERAPY OF THROMBOEMBOLIC DISEASE.
    COON WW; PENNER JA
    Surg Gynecol Obstet; 1964 Sep; 119():495-502. PubMed ID: 14210147
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and pathological studies: thrombolytic activity and related phenomena.
    VERSTRAETE M
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():328-9. PubMed ID: 13996899
    [No Abstract]   [Full Text] [Related]  

  • 6. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.
    HAWKEY C; HOWELL M
    J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
    AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C
    Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831
    [No Abstract]   [Full Text] [Related]  

  • 8. THE INHIBITORY EFFECT OF LARGE CONCENTRATIONS OF STREPTOKINASE AS RELATED TO PROTEOLYTIC ACTIVITY AND PROACTIVATOR FUNCTION OF HUMAN EUGLOBULIN.
    HELLE I
    Scand J Haematol; 1964; 1():240-56. PubMed ID: 14214904
    [No Abstract]   [Full Text] [Related]  

  • 9. TREATMENT OF PERIPHERAL VASCULAR OCCLUSION BY STREPTOKINASE PERFUSION.
    MCNICOL GP; DOUGLAS AS
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:23-9. PubMed ID: 14199705
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 11. ACTIVATION OF RABBIT PLASMINOGEN BY STREPTOKINASE.
    CHATTOPADHYAY DP; CLIFFTON EE
    Am J Physiol; 1965 Jan; 208():190-7. PubMed ID: 14253148
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 13. THE INFLUENCE OF FIBRINOGENOLYTIC AND FIBRINOLYTIC SPLIT PRODUCTS ON THE LAST STAGE OF COAGULATION.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():327-30. PubMed ID: 14073280
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE PERFORMANCE OF THROMBOLYTIC TREATMENT WITH STREPTOKINASE].
    WINCKELMANN G; HELMS M
    Med Klin; 1963 Sep; 58():1568-71. PubMed ID: 14050317
    [No Abstract]   [Full Text] [Related]  

  • 16. [EFFECT OF FIBRINOLYTIC ACTION FOUND IN ASCITES OF EHRLICH CANCER CELL IN MICE].
    HIRATA T
    Kobe Ika Daigaku Kiyo; 1963 Dec; 25():1-9. PubMed ID: 14117791
    [No Abstract]   [Full Text] [Related]  

  • 17. FIBRINOLYSIS AND THE PLASMA PROTEIN ELECTROPHORETIC PATTERN.
    BIELAWIEC M; NILSSON IM
    Scand J Clin Lab Invest; 1964; 16():513-20. PubMed ID: 14209211
    [No Abstract]   [Full Text] [Related]  

  • 18. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 19. [CLINICAL EXPERIENCE WITH STREPTOKINASE AS A THROMBOLYTIC AGENT].
    VERSTRAETE M; AMERY A
    Acta Cardiol; 1963; 18():235-47. PubMed ID: 14045888
    [No Abstract]   [Full Text] [Related]  

  • 20. STUDIES ON THE CLOT-PROMOTING EFFECT OF LARGE CONCENTRATIONS OF STREPTOKINASE.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():375-9. PubMed ID: 14073286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.